Sleep–wake regulation arises from the interaction between homeostatic sleep pressure and circadian timing, yet current assessments evaluate these processes independently and fail to capture their dynamic modulation by environmental pressures. This limitation is particularly relevant in adolescents with attention-deficit/hyperactivity disorder (ADHD), who are at increased risk of circadian delay and sleep disruption.

Here, we combined month-long wearable-based physiological monitoring with ecological behavioral assessments in adolescents with ADHD to characterize circadian and homeostatic processes dynamically in real-world settings. Using continuous skin temperature recordings, we derived individualized and day-specific estimates of circadian phase through hierarchical modelling, and integrated these measures with actigraphy-based sleep estimates and daily assessments of neurocognitive functioning and functional impairment.

Temperature-derived circadian phase correlated with questionnaire-based chronotype but more accurately predicted sleep patterns. Delayed circadian phase was associated with later sleep onset and greater weekday–weekend variability. Importantly, circadian phase exhibited significant day-to-day fluctuations, particularly in individuals with delayed phase, reflecting interactions with environmental constraints. Sleep latency was jointly determined by homeostatic sleep pressure and day-specific circadian phase, with combined models outperforming either process alone.

Crucially, both sleep deprivation and day-specific circadian misalignment independently predicted fluctuations in ADHD symptom severity, perceived stress, and neurocognitive impulsivity. In contrast, mean circadian phase alone did not explain behavioral variability.

These findings demonstrate that circadian regulation is a dynamic, environmentally sensitive process rather than a fixed trait. Wearable-based estimation of circadian phase provides a scalable approach to capture these dynamics and may enable personalized interventions targeting sleep and circadian dysregulation.

The authors have declared no competing interest.

This study was supported by the Swiss National Science Foundation (SNSF; Grant No. 320030_212476 to SE and 10002308 to MS). Corrado Sandini was supported by an SNSF grant (No. 209096) and by the Fondation Gertrude von Meissner (Grant No. 52, March 2025). Natacha Reich received a scholarship from the Fondation Pôle Autisme.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Commission Cantonale d'Ethique de la Recherche sur l'etre humain (CCER) of Canton de Geneve gave ethical approval for this work

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors